Sched.com Conference Mobile Apps
DIA 2025 Global Annual Meeting
DIA 2025 Global Annual Meeting
Sign up
or
log in
to bookmark your favorites and sync them to your phone or calendar.
Schedule
Speakers
Search
Menu
Schedule
Speakers
Search
Mercy Owusu-Asante
University of Hertfordshire, United Kingdom
Graduate Student, School of Life and Medical Sciences
Chelsea O'Connell
Amgen, United States
Director, Global Regulatory Policy & Intelligence
CO
Catina O'Leary
Health Literacy Media, United States
President and Chief Executive Officer
William Palo
AbbVie, United States
Director, Safety Statistics
RP
Renata Parca
ANVISA, Brazil
Health regulatory specialist
VP
Valerie Parker
Duke Margolis Institute For Health Policy, United States
Assistant Research Director
Jaymin Patel
AESARA, United States
HEOR
MP
Mayur Patel
AstraZeneca, United States
Vice President, Oncology Therapy Area, Global Patient Safety
Timil Patel
FDA, United States
Clinical Team Lead (Acting), Division of Oncology 2, FDA
EP
Elisabetta Patorno
Brigham and Women's Hospital; Harvard Medical School, United States
Associate Professor of Medicine
JP
Julie Patterson
National Pharmaceutical Council, United States
Senior Director of Research
Y. Veronica Pei
FDA, United States
Acting Associate Director, Biomedical Informatics and Regulatory...
MP
Michael Pelosi
Astellas, United States
Director, Quality Analytics
Ruonan Peng
University of California, Riverside, United States
Graduate Research Assistant
DP
Daniel Pereira
ANVISA, Brazil
Eleanor Perfetto
Consultant, United States
Independent Consultant
Vada A. Perkins
Boehringer Ingelheim, United States
Vice President, Global Head of Regulatory Intelligence & Policy
Maryrose Petrizzo
Clinical Quality Assured,LLC, United States
President and Consultant
Yen Phan
University of Oxford, Ireland
Student
Carie Pierce
DIA, United States
Global Head of Growth & Business Development
Maria Cristina Mota Pina
AbbVie, United States
Head, Regulatory Policy for Emerging Markets -Japan and Australia
Elena Popa
Bayer, Switzerland
Chief of Staff, Global Regulatory Affairs
Johann Proeve
Cyntegrity, Germany
Chief Scientific Officer
Stephen Pyke
Parexel, United Kingdom
Chief Clinical Data and Digital Officer
AR
Adriana Racolta
Pfizer Inc, United States
Director, Regulatory Affairs, Companion Diagnostics
Sophie Radicke
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of GPvP and Senior Pharmacovigilance Inspector
AR
Allison Radwick
U.S. Pharmacopeia, United States
Senior Regulatory and Policy Communications Manager
MR
Mohit Raizada
IQVIA, India
Director - Signal Management Services
AR
Aysha Rana
Spectra Medical/Northeastern Universitu, United States
Regulatory Affairs Specialist
DR
Diogo Rao
Eli Lilly, United States
Chief Information Officer
CR
Chantelle Rein-Smith
Whitsell Innovations, Inc., United States
Principal Medical Writer and Consultant
Matthew Renda
Alexion, Astrazeneca Rare Disease, United States
Senior Director Medical Writing Operations
LR
Linda Reuter
BRANY IRB, United States
Senior Director
Kim Ribeiro
Inside Edge Consulting Group, United States
Chief Client Officer
Brandon Rice
Weave Bio, United States
CPO
Katrina Rice
eClinical Solutions, United States
Chief Delivery Officer, Biometrics Services
KR
Kevin Richards
AstraZeneca, Canada
Head Quality Investigations & Analytics
Nicole Richie
Genentech, United States
Vice President & Global Head Health Equity & Population...
Lia Ridout
N/A, United States
Patient Advocate
Amanda Roache
PhRMA, United States
Deputy Vice President, Science and Regulatory Advocacy
SR
Sarah Roberge
WCG Clinical, United States
IBC Chair, IBC Services
Sajida Roberson
Independent Consultant, United States
Business Transformation
Samantha Roberts
AstraZeneca, United States
Senior Director, Regulatory Intelligence
MR
Matthew Robillard
AbbVie, United States
Senior Director, Regulatory Strategic Writing
Kelly Robinson
Health Canada, Canada
Director General, Marketed Health Products Directorate
WR
Warren Roche
Sanofi, Ireland
Statistician
LR
Lesbeth Rodriguez
Bayer, United States
Director, Regulatory Affairs Policy and Science
PR
Patrick Rodriguez
Duke-Margolis Institute For Health Policy, United States
Policy Analyst
Carla Rodriguez-Watson
Reagan-Udall Foundation for the FDA, United States
UR
Ulrich Rohr
Swissmedic, Switzerland
Unit Head Clinical Review
Maria Antonieta Roman
Novartis, Mexico
Head Regulatory Policy Emerging Markets LATAM
Peter Ronco
Emmes, United States
CEO
Patricia Roselle
Sanofi, United States
Head of Patient Stakeholder Engagement
Len Rosenberg
Beat AML, a division of The Leukemia and Lymphoma Society, United States
Head of Clinical Operations
David Ross
AstraZeneca, United States
Senior Director, Regulatory Data and Submissions
DR
Dawn Rotellini
National Bleeding Disorder Foundation, United States
Chief Operating Officer
Cynthia Rothblum-Oviatt
FDA, United States
Science Policy Analyst, Rare Disease Team, OND, CDER
Mark Rothmann
FDA, United States
Division Director, OTS, OB, CDER
Todd Rudo
Clario, United States
EVP & Chief Medical Officer
Lisa Ruiz
Abbvie, United States
VP, Regulatory Affairs Operations, CMC & Device
PR
Patrick Ryan
Janssen Pharmaceuticals, Inc., United States
Vice President Observational Health Data Analytics
AS
Arman Sabbaghi
Unlearn, United States
Head of Biostatistics Research
AS
Arman Sabbaghi
Purdue University, United States
Associate Professor of Statistics
BG
Budi Gunadi Sadikin
Ministry of Health, Indonesia
Minister
RS
Reza Salehzadeh-Asl
Health Canada, Canada
National Supervisor Clinical Trial Compliance Program
Leslie Sam
Leslie Sam and Associates, LLC, United States
President
Toshiharu Sano
MSD, Japan
Associate Vice President
DS
Dandara Santana
ANVISA, Brazil
CMC reviewer
DS
Daniele Sartori
Uppsala Monitoring Centre, Sweden
Senior Pharmacovigilance Scientist
Junko Sato
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
PS
Patrick Saunders
Eli Lilly & Co., United States
Senior Director, Quality, Lilly del Caribe
Anja Schiel
Norwegian Medicines Agency (NoMA), Norway
Special Advisor, Lead Methodologist/Statistician; NoMA
Carrie Scott
AbbVie Ltd, Portugal
Head, Global PV Compliance and Policy, Pharmacovigilance and Patient...
RS
Rohini Sen
AbbVie, United States
Director, HEOR
IS
Imran Shah
EMD Serono, United States
SVP & Head, Global Regulatory, R&D Quality and Safety (RQS)
Saad Shakir
ADROITVIGILANCE, United Kingdom
Pharmacovigilance Physician and Pharmacoepidemiologist
Saad Shakir
Drug Safety Research Unit, United Kingdom
Director
Raja Shankar
IQVIA, United Kingdom
Vice President, Machine Learning
AS
Ana Sharma
Abivax, United States
Global Head of Quality
JS
John Sharretts
FDA, United States
Director at Division of Diabetes, Lipid Disorders, and Obesity
MS
Molly Shields
Duke-Margolis Institute For Health Policy, United States
Policy Research Assistant
Allison Cuff Shimooka
TransCelerate Biopharma Inc, United States
Chief Operating Officer
Judy Shin
School of Pharmacy, Sungkyunkwan University, Korea, Republic of
Professor
Sooyoon Shin
Verily, United States
Senior Manager, Digital Biomarkers
CS
Carolyn Shore
National Academies, United States
Senior Program Officer
AS
Anand Shroff
Verantos, United States
President
RS
Ria Siagian
Indonesia Food and Drug Authority, Indonesia
Director, Drug Registration Directorate
Steve Sibley
Certara, United States
Vice President, Global Submissions and Submissions Leadership
Hiiti Sillo
World Health Organization (WHO), Switzerland
Unit Head, Regulation and Safety, Department of Regulation and...
Dyke Simpson
Syneos Health , United States
Executive Managing Director and Lead, Data, AI & Analytics...
Louise Lind Skov
Novo Nordisk A/S, Denmark
Head of Content Digitalisation
AS
Aaron Smith
Unlearn.AI, United States
Founder, Machine Learning Scientist
Cary Smithson
LeapAhead Solutions, Inc., United States
Managing Partner
Rachel Sobel
Regeneron Pharmaceuticals Inc., United States
Vice President, Head of Pharmacoepidemiology & Risk Management...
Mariana Socal
Johns Hopkins Bloomberg School of Public Health, United States
Associate Professor
Cecilia Speck
Novartis, United States
Post-Doctoral Fellow
Dianne Spillman
FDA, United States
Associate Director, Global and Regulatory Outreach, OCE
Alicia Staley
Medidata, a Dassault Systèmes Company, United States
Chief Patient Officer
Nicole Stansbury
Premier Research, United States
Senior Vice President Global Clinical Operations
Jens Stegmann
GSK , Belgium
Senior Vice President, Head Clinical Safety and Pharmacovigilance and...
ES
Eddie Stern
The Breathing App, Inc, United States
CEO
AS
Alan Stevens
Abbvie, United States
Global Head, Complex Devices and Drug Delivery Systems
Mark Stewart
Friends of Cancer Research, United States
Vice President, Science Policy
Yoshiko Stowell
Kenai Therapeutics, United States
Vice President Regulatory Affairs
Walter Straus
Moderna, United States
Vice President, Safety and PV
Carmit Strauss
Takeda, United States
Executive Director, Head of Risk Management and Organ Toxicity
Margaret Studzinska
MMS Holdings, United States
Senior Director, Regulatory and Medical Writing
Nancy Styple
Bayer AG, United States
Project Management Leader
Ling Su
Shenyang Pharmaceutical University, Yeehong Business School, China
Research Fellow
Yu Fa Su
Taiwan Center For Drug Evaluation, Taiwan
Project Manager
IR
Indri Rooslamiati Supriadi
Indonesia Ministry of Health, Indonesia
Director, Center for Biomedical and Health Genomics and INA-CRC
Andreas Sutter
Bayer AG, Germany
Senior Program Management Leader
Toru Suzuki
Novartis Pharma, Japan
Head, Regulatory and Development policy
Kimberly Tableman
Espero, United States
Founder & CEO
QT
Qian Tang
University of Iowa, United States
ST
Sarah Tanios
FDA, United States
ST
Sarah Tanios
Purdue University, United States
Fellow
Rosa Tarng
Takeda, United States
Translational Program Management
BT
Barrett Tenbarge
U.S. Senate HELP Committee, United States
General Counsel
Jessica Thompson
Clinical Research Pro, United States
Founder, CEO
Gert Thurau
F. Hoffmann-La Roche Ltd, Switzerland
Head of Manufacturing Technology Innovation in CMC Regulatory Policy
Jayashree Tikhe
Dassault Systemes, United States
Senior Product Marketing Manager
Lauren Tobe
Eli Lilly and Company, United States
Director, Regulatory Policy and Strategy
Darren Toh
Harvard Medical School and Harvard Pilgrim Health Care Institute, United States
Professor
Natalie Tolli
AbbVie, Inc., United States
Vice President, Regulatory Affairs
Michael Torok
Genentech, A Member of the Roche Group, United States
Vice President, Global Head of Quality Assurance Programs
ST
Sharleen Traynor
Durham Tech, United States
Instructor
Sarah Tremethick
Roche Products Limited, United Kingdom
Global Consortia Program Lead and Global Member Network Executive...
Kiernan Trevett
Genentech, A Member of the Roche Group, United States
Quality Policy Lead
Jennifer Trevor
Astellas, United States
Director-Global Category Lead- Development
JT
Julie Tripp
Mind Medicine Inc., United States
Senior Director of Toxicology
DT
Darshini Trivedi
Amgen, Inc, United States
Senior Director, Global Regulatory Affairs and Product Strategy
Ran Tu
Georgetown University, United States
Phd Student
Jennifer Tucker
Roche Diagnostics, United States
Global Head of Regulatory Affairs, Pathology Lab
Cathy Tyrrell
Seqirus, United States
Head of Medical Writing and Disclosure
Yoshiaki Uyama
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Pujita Vaidya
Sanofi, United States
Director, Regulatory Science and Policy
James Valentine
Hyman, Phelps & McNamara, PC, United States
Director
JV
Jacqueline Vanderpuye-Orgle
Parexel, United States
Vice President
Alice Vanneste
KU Leuven, Belgium
PhD Student
Maria Vassileva
DIA, United States
Chief Science and Regulatory Officer
CV
Chris Venezia
ProofPilot, United States
Chief Executive Officer
RV
Rishi Verma
Roche & Stethy, Australia
Medical Director
Rebecca Vermeulen
Genentech, A Member of the Roche Group, United States
Vice President, Global Patient Networks | PD Medical Affairs
Alyssa Vincze
Milliman IntelliScript , United States
Principal and Director, R&D
MV
Mukul Virmani
Gilead, United States
Director, Clinical Data Science, AI Research Center
James Wabby
AbbVie, United States
Global Head, Regulatory Affairs, Emerging Technologies and...
Jason Wakelin-Smith
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Expert GCP Inspector and Head of Compliance Expert Circle
Paula Walker
Roche Products Ltd., United Kingdom
Global Head of Risk Based Quality Management
EW
Echo Wang
Merck & Co., Inc, United States
Director, Outcome Research
JW
Jialu Wang
Vertex Pharmaceuticals, United States
Statistician
Shirley Wang
Harvard Medical School, United States
Associate Professor of Medicine
Wenquan Wang
Pfizer, United States
Senior Director
William Wang
Merck & Co, Inc, United States
President
SW
Shinya Watanabe
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer (Epidemiology)
DW
Doug Weatherhead
ESPERO, United States
Chief Commercial Officer
EW
Eli Weinberg
Bain & Co., United States
Partner
Ria Westergaard
Evernorth Clinical Trial and RWE Solutions, United States
Head of Product Strategy and Innovation
MW
Madeleine Whitehead
Roche, United Kingdom
RBQM CoE - Head
Robin Whitsell
Whitsell Innovations, Inc., United States
President
Jenna Wildeman
University of Washington, United States
PharmD Candidate
Jamie Wilkins
Pfizer Inc, United States
Head, Risk Management Center of Excellence
KW
Kim Wilkinson
Alexion RDU, Astrazeneca, United States
Associate Director, Medical Writing
DW
Donald Williams
Boehringer Ingelheim Pharmaceuticals, Inc., United States
Global Patient Safety and Pharmacovigilance, Regulatory Reporting
GW
GINA Williamson
Illingworth, A Syneos Health Company, Spain
Principal Site solutions
Luman Wing
Management Consultants, United States
Consultant, Nonclinical
Steve Winitsky
Parexel International, United States
Senior Vice President, Technical
Leanne Woehlke
SOGLIA - Entrada Ventures, United States
Executive Vice President, SOGLIA
Jerzy Wojcik
EdgeOne Medical, United States
VP, Regulatory & Quality Services
Thad Wolfram
EmVenio Research, United States
Chief Strategy Officer
MW
Marion Wolfs
Johnson & Johnson, Netherlands
Associate Director Risk Management & Central Monitoring
SW
Shyard Wong
Sanofi, France
Global Head, Clinical Quality and Continuous Improvement
MW
Mathew Woodwark
AstraZeneca, United Kingdom
Head of Data Standards and Interoperability
Gillian Woollett
Samsung Bioepis, United States
Vice President, Head Regulatory Strategy and Policy
Benjamin Worley
Labconnect, United States
Senior Director, Sustainability and ESG
Amy Xia
Amgen Inc., United States
Vice President, Center for Design and Analysis
RX
Richard Xie
RA Capital, United States
Senior Health Economist
BY
Baiyu Yang
Roche Molecular Systems, United States
Principal Quantitative Scientist
DY
David Yao
Novartis, United States
Associate Director, Regulatory Affairs CMC
Tarik Yardibi
Takeda Pharmaceuticals, United States
Director, Sensing and Measurement
Takayuki Yasuda
Chugai Pharmaceutical Co., Ltd., Japan
Statistical Programmer
Amira Younes
MSD, United Arab Emirates
Director, Global Regulatory Policy EEMEA
Rumi Young
Novo Nordisk, United States
Director, Regulatory Policy
Shou Yuan
Taimei Technology Inc., United States
Director, Global Solutions
CZ
Chenan Zhang
Pfizer, United States
Director, Epidemiology
DZ
Di Zhang
Teva, United States
Associate Director of RWE Statistics
TZ
Teresa Zhang
Beigene, United States
Safety Scientist
XZ
Xiang Zhang
CSL Behring, United States
Head of Medical Affairs and HTA Statistics/Co-lead FORExcellence
LZ
Liang Zhao
University of California San Francisco, United States
Director for Global Regulatory Science and Innovation
Siqian Zheng
University of Macau, China
Doctor of Biomedical sciences
John Zhong
REGENXBIO, Inc., United States
Vice President, Head of Biometrics
Martine Zimmermann
Ipsen , France
Senior Vice President, Head of Global Regulatory Affairs
Bianca Zimon
ANVISA, Brazil
Health Regulation Specialist
Vadim Zipunnikov
Johns Hopkins Bloomberg School of Public Health, United States
Associate Professor
MZ
Maya Zlatanova
Findmecure Ltd., Bulgaria
CEO & Co-founder
Andrea Zuleta
Abbvie, United States
Manager, Office of Health Literacy
CZ
Cecilia Zvosec
ZS, United States
Strategy & Insights
1
2
3
Share Modal
Share this link via
Or copy link
Copy
